9,884
Total Claims
$1.8M
Drug Cost
990
Beneficiaries
$1,859
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+22%
Cost per patient vs peers
$1,859 vs $1,524 avg
+66%
Brand preference vs peers
22.6% vs 13.7% avg
Brand vs Generic
77% generic
Brand: 2,233 claims · $1.7M
Generic: 7,651 claims · $132K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 614 | $463K |
| Empagliflozin | 593 | $446K |
| Sacubitril/Valsartan | 270 | $226K |
| Apixaban | 210 | $168K |
| Ticagrelor | 160 | $98K |
| Rivaroxaban | 139 | $91K |
| Amlodipine Bes/Olmesartan Med | 266 | $16K |
| Metoprolol Succinate | 680 | $11K |
| Evolocumab | 18 | $11K |
| Empagliflozin/Linagliptin | 15 | $9,023 |
| Atorvastatin Calcium | 842 | $8,985 |
| Chlorthalidone | 312 | $8,969 |
| Vericiguat | 12 | $7,766 |
| Candesartan Cilexetil | 76 | $7,377 |
| Candesartan/Hydrochlorothiazid | 46 | $5,199 |
Prescribing Profile
67
Unique Drugs
$1.4M
Patient Profile
72
Avg Age
59%
Female
2.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data